IVD newsletter - Q1 2026, Issue 52
IVD
Microlab’s Abacavir (as sulfate)/Dolutegravir (as sodium)/Lamivudine Dispersible Tablet, 60 mg/5 mg/30 mg prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s Isoniazid 100mg dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified l
Mylan’s Bedaquiline 100mg tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified l
Renata’s Ethinylestradiol/Levonorgestrel 30µg/150µg Tablet, with Ferrous Fumarate Tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified l
Expansion of the Insulin Master File Procedure to Insulin Analogues
M
Access to affordable insulin remains a critical public health priority.
Active Pharmaceutical Ingredient (API) Prequalified
M
Darunavir (ethanolate) manufactured by Arene Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
This week (23-27 March 2026), the Prequalification Medicines Team is conducting its 150th Medicines Assessment Session
M
The journey began 25 years ago in 2001 with the guiding motto “working for countries, with countries,” marked by the convening